[1]孙荣,吴宙光,叶泳钦,等.GPC1在胆道闭锁患儿肝组织中表达水平及临床意义的初步探索[J].临床小儿外科杂志,2019,18(03):211-215.[doi:10.3969/j.issn.1671-6353.2019.03.010]
 Sun Rong,Wu Zhouguang,Ye Yongqin,et al.Preliminary study on the expression level and clinical significance of GPC1 in liver tissues of children with biliary atresia[J].Journal of Clinical Pediatric Surgery,2019,18(03):211-215.[doi:10.3969/j.issn.1671-6353.2019.03.010]
点击复制

GPC1在胆道闭锁患儿肝组织中表达水平及临床意义的初步探索

参考文献/References:

1 Asai A, Miethke A, Bezerra JA.Pathogenesis of biliary atresia:defining biology to understand clinical phenotypes[J].Nat Rev Gastroenterol Hepatol, 2015, 12(6):342-345.DOI:10.1038/nrgastro.2015.74.
2 Wen J, Xiao Y, Wang J, et al.Low doses of CMV induce autoimmune-mediated and inflammatory responses in bile duct epithelia of regulatory T cell-depleted neonatal mice[J].Lab Invest, 2015, 95(2):180-192.DOI:10.1038/labinvest.2014.148.
3 郭振亚, 张若岩, 柳明江, 等.先天性胆道闭锁的病因研究进展[J].临床肝胆病杂志, 2015, 31(8):1343-1346.DOI:10.3969/j.issn.1001-5256.2015.08.043. Guo ZY, Zhang RY, Liu MG, et al.Etiology of congenital biliary atresia[J].Journal of Clinical Hepatobiliary Diseases, 2015, 31(8):1343-1346.DOI:10.3969/j.issn.1001-5256.2015.08.043.
4 Tang V, Cofer ZC, Cui S, et al.Loss of a candidate biliary atresia susceptibility gene, add3a, causes biliary developmental defects in zebrafish[J].J Pediatr Gastroenterol Nutr, 2016, 63(5):524-530.DOI:10.1097/MPG.0000000000001375.
5 李智涵, 王斌.Ⅲ型胆道闭锁手术治疗的研究进展[J].临床小儿外科杂志, 2016, 15(1):11-13.DOI:10.3969/j.issn.1671-6353.2016.01.004.Li ZH, Wang B.Advances in surgical treatment of biliary atresia of type Ⅲ[J].J Clin Ped Sur, 2016, 15(1):11-13.DOI:10.3969/j.issn.1671-6353.2016.01.004.
6 Asai A, Miethke A, Bezerra JA.Pathogenesis of biliary atresia:defining biology to understand clinical phenotypes[J].Nat Rev Gastroenterol Hepatol, 2015, 12(6):342-352.DOI:10.1038/nrgastro.2015.74.
7 Hill JJ, Tremblay TL, Fauteux F, et al.Glycoproteomic comparison of clinical triple-negative and luminal breast tumors[J].Journal of Proteome Research, 2015, 14(3):1376-1388.DOI:10.1021/pr500987r.
8 Sadek KH, Ezzat S, Abdel-Aziz SA, et al.Macrophage migration inhibitory factor (MIF) gene promotor polymorphism is associated with increased fibrosis in biliary atresia patients, but not with disease susceptibility[J].Ann Hum Genet, 2017, 81(5):177-183.DOI:10.1111/ahg.12199.
9 Tang V, Cofer ZC, Cui S, et al.Loss of a candidate biliary atresia susceptibility gene, add3a, causes biliary developmental defects in zebrafish[J].J Pediatr Gastroenterol Nutr, 2016, 63(5):524-530.DOI:10.1097/MPG.0000000000001375.
10 Leyva-Vega M, Gerfen J, Thiel BD, et al.Genomic alterations in biliary atresia suggest region of potential disease susceptibility in 2q37.3[J].Am J.Med.Genet.A, 2010, 152A(4):886-895.DOI:10.1002/ajmg.a.33332.
11 Cui S, Leyva-Vega M, Tsai EA, et al.Evidence from human and zebrafish that GPC1 is a biliary atresia susceptibility gene[J].Gastroenterology, 2013, 144(5):1107-1115.DOI:10.1053/j.gastro.2013.01.022.
12 Ke J, Zeng S, Mao J, et al.Common genetic variants of GPC1 gene reduce risk of biliary atresia in a Chinese population[J].J Pediatr.Surg, 2016, 51(10):1661-1664.DOI:10.1016/j.jpedsurg.2016.05.009.
13 Melo SA, Luecke LB, Kahlert C, et al.Glypican-1 identifies cancer exosomes and detects early pancreatic cancer[J].Nature, 2015, 523(7559):177-182.DOI:10.1038/nature14581.
14 Lu H, Niu F, Liu F, et al.Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma[J].Cancer Med, 2017, 6(6):1181-1191.DOI:10.1002/cam4.1064.
15 Hara H, Takahashi T, Serada S, et al.Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma[J].Br J Cancer, 2016, 115(1):66-75.DOI:10.1038/bjc.2016.183.
16 Lai X, Wang M, McElyea SD, et al.A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer[J].Cancer letters, 2017, 393(1):86-93.DOI:10.1016/j.canlet.2017.02.019.
17 Li J, Li B, Ren C, et al.The clinical significance of circulating GPC1 positive exosomes and its regulative miRNAs in colon cancer patients[J].Oncotarget, 2017, 8(60):101189-101202.DOI:10.18632/oncotarget.20516.
18 Chamorro-Jorganes A, Araldi E, Rotllan N, et al.Autoregulation of glypican-1 by intronic microRNA-149 fine tunes the angiogenic response to FGF2 in humanendothelial cells[J].J Cell Sci, 2014, 127(6):1169-1178.DOI:10.1242/jcs.130518.

相似文献/References:

[1]毛永忠,汤绍涛,阮庆兰,等.胆道闭锁肝组织MMP-1、MMP-2、TIMP-1的表达与预后研究[J].临床小儿外科杂志,2007,6(01):5.
[2]毛永忠,汤绍涛,阮庆兰,等.胆道闭锁肝脏组织MMP-2、TGF-β_1的表达及意义[J].临床小儿外科杂志,2007,6(03):5.
[3]余梦楠 刘钢 黄柳明 王伟. 胆道闭锁术后反复发作性胆管炎的细菌谱分析及抗生素选择[J].临床小儿外科杂志,2012,11(03):187.
 [J].Journal of Clinical Pediatric Surgery,2012,11(03):187.
[4]董淳强 杨体泉 董昆. 胆道闭锁术后早期胆管炎风险因素分析[J].临床小儿外科杂志,2013,12(05):348.
[5]陈功 郑珊 孙松. 不同年龄胆道闭锁患儿手术效果分析[J].临床小儿外科杂志,2014,13(01):22.
[6]谭梅军 陶强 黄金狮. IL-17在胆道闭锁患儿肝组织中的表达及意义[J].临床小儿外科杂志,2014,13(04):302.
[7]杨文萍 吴艳 张守华. 胆道闭锁患者肝脏组织病理改变的综合评价[J].临床小儿外科杂志,2015,14(01):10.
[8]李康 阳历 汤绍涛. 胆道闭锁患者肝内胆管γδT 细胞和调节性T细胞浸润及意义[J].临床小儿外科杂志,2015,14(01):16.
[9]刘丹丹 詹江华 高伟. 胆道闭锁患者肝门的病理解剖学研究[J].临床小儿外科杂志,2015,14(01):20.
[10]张震 李龙 乔国梁. 胆道闭锁Kasai术后生存率及条件生存率分析[J].临床小儿外科杂志,2015,14(01):25.

备注/Memo

收稿日期:2018-09-13。
基金项目:国家自然科学基金(编号:81770512)
通讯作者:王斌,Email:szwb1967@126.com

更新日期/Last Update: 1900-01-01